BRIEF-Biondvax Plans Phase 3 Clinical Trial Following Receipt Of Scientific Advice From The European Medicines Agency
December 27, 2017 at 09:08 AM EST
* BIONDVAX PLANS PHASE 3 CLINICAL TRIAL FOLLOWING RECEIPT OF SCIENTIFIC ADVICE FROM THE EUROPEAN MEDICINES AGENCY (EMA)